文献速递临床生化临床免疫

终末期肾病患者心脏肌钙蛋白T分子形式小于急性心梗发作后

Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction.
PubMed 文献 · Clin Chem · 2017-01-10

该研究通过凝胶过滤色谱分析发现,终末期肾病(ESRD)患者血液中的心脏肌钙蛋白T(cTnT)主要为一个45 mL洗脱峰,对应缺失N端和C端的<18 kDa片段,且透析前后及2个月随访稳定。而急性心肌梗死(AMI)患者血清出现27.5 mL和45 mL两个峰,分别对应N端截短的29 kDa cTnT和<18 kDa片段。提示ESRD与AMI的cTnT形式不同,可能有助于开发更特异的cTnT免疫检测。

要点

  • ESRD患者cTnT以<18 kDa小片段为主,缺失N端和C端。
  • AMI患者cTnT包含29 kDa N端截短形式和<18 kDa片段。
  • ESRD患者cTnT形式在透析前后及2个月随访中稳定。

核心结论

  • ESRD患者cTnT形式为<18 kDa小片段,不同于AMI患者的形式。
  • 这些发现可能有助于开发更特异的cTnT免疫检测,尤其用于心梗急性诊断期。

研究设计与样本

  • 研究采用凝胶过滤色谱(GFC)分离cTnT形式,样本包括ESRD患者透析前和透析后(n=10)及2个月随访(n=6)。
  • 同时分析纯化cTnT标准品、临床cTnT免疫检测(Roche)质控品和AMI患者血清。
  • 采用免疫沉淀和Western blotting,使用临床检测原始cTnT抗体及抗cTnT N端和C端抗体。

主要发现

  • 纯化cTnT在GFC中保留体积为27.5 mL,与质控品中cTnT一致。
  • 所有ESRD患者(透析前、透析后及随访)均仅见一个45 mL cTnT峰,对应<18 kDa且缺失N端和C端的片段。
  • AMI患者血清显示27.5 mL和45 mL两个cTnT峰,分别对应N端截短的29 kDa cTnT和N端及C端截短的<18 kDa片段。

临床怎么用

  • 临床解读ESRD患者cTnT升高时需考虑其分子形式为<18 kDa小片段,与AMI不同。
  • 该发现可能为开发更特异的cTnT免疫检测提供依据,尤其针对心梗急性诊断期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We have found previously that in acute myocardial infarction (AMI), cardiac troponin T (cTnT) is degraded in a time-dependent pattern. We investigated whether cTnT forms differed in patients with chronic cTnT increases, as seen with renal dysfunction, from those in the acute phase of myocardial infarction. METHODS: We separated cTnT forms by gel filtration chromatography (GFC) in end-stage renal disease (ESRD) patients: prehemodialysis (pre-HD) and post-HD (n = 10) and 2 months follow-up (n = 6). Purified (cTnT) standards, quality control materials of the clinical cTnT immunoassay (Roche), and AMI patients' sera also were analyzed. Immunoprecipitation and Western blotting were performed with the original cTnT antibodies from the clinical assay and antibodies against the N- and C-terminal end of cTnT. RESULTS: GFC analysis revealed the retention of purified cTnT at 27.5 mL, identical to that for cTnT in quality controls. For all ESRD patients, one cTnT peak was found at 45 mL, pre- and post-HD, and stable over time. Western blotting illustrated that this peak corresponded to cTnT fragments <18 kDa missing the N- and C-terminal ends. AMI patients' sera revealed cTnT peaks at 27.5 and 45 mL, respectively, corresponding to N-terminal truncated cTnT of 29 kDa and N- and C-terminal truncated fragments of <18 kDa, respectively. CONCLUSIONS: We found that cTnT forms in ESRD patients are small (<18 kDa) and different from forms seen in AMI patients. These insights may prove useful for development of a more specific cTnT immunoassay, especially for the acute and diagnostic phase of myocardial infarction.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Mingels AM, Cardinaels EP, Broers NJ, et al. Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction. Clin Chem. 2017. PMID: 28073901. doi:10.1373/clinchem.2016.261644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。